Adverse Effects of Amoxicillin in Pediatric Patients

Introduction to Adverse Effects

• The American Academy of Pediatrics recommends that antibiotics are responsible for the largest number of unplanned medical visits for medication-related adverse events among children, exceeding 150,000 per year 1
• Growing evidence suggests early-life antibiotic exposures may disrupt microbial balance, potentially contributing to inflammatory bowel disease, obesity, eczema, and asthma 1, 2

Risk of Adverse Events

• Meta-analyses of studies comparing antibiotic treatment to placebo for acute otitis media suggest approximately 5% increased rate of adverse events, particularly diarrhea and rash 1
• In sinusitis treatment trials, adverse events (rash, diarrhea, vomiting, and abdominal pain) occurred in 44% of patients treated with high-dose amoxicillin-clavulanate compared with 14% in the placebo group 1

Clinical Considerations

• When prescribing amoxicillin, carefully weigh potential benefits against harms, especially for upper respiratory tract infections where benefits may be limited to symptom attenuation 1
• Apply stringent diagnostic criteria before prescribing amoxicillin, as prescribing for nonspecific URI and colds generally provides no benefit while exposing patients to potential harm 1, 3